Gefitinib Enhances the Antitumor Activity of CPT-11 in vitro and in vivo by Inhibiting ABCG2 but Not ABCB1: A New Clue to Circumvent Gastrointestinal Toxicity Risk
Publisher: Karger
E-ISSN: 1421-9794|59|4|260-272
ISSN: 0009-3157
Source: Chemotherapy, Vol.59, Iss.4, 2014-01, pp. : 260-272
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Chemotherapy, Vol. 49, Iss. 3, 2003-06 ,pp. :